02591 銀諾醫藥－Ｂ
按盤價 
41.840 +0.060 (+0.144%) | 日期 | 股東名稱 | 披露原因 | 買入／賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 15/08/2025 | KOREA INVESTMENT HOLDINGS Co., Ltd. | 1701(L) | +41,731,556(L) | 41,731,556(L) | 9.93 | |
| 15/08/2025 | KOREA INVESTMENT & SECURITIES Co., Ltd | 1701(L) | +26,556,444(L) | 26,556,444(L) | 6.32 | |
| 15/08/2025 | Hong Kong Innogen Pharmaceutical Technology Co., Limited | 1701(L) | +2,550,044(L) | 2,550,044(L) | 6.98 | |
| 15/08/2025 | Shanghai Nuotang Biotechnology Co., Ltd. | 1701(L) | +52,299,799(L) | 52,299,799(L) | 12.44 | |
| 15/08/2025 | Shanghai Nuotang Biotechnology Co., Ltd. | 1701(L) | +13,074,949(L) | 13,074,949(L) | 35.79 | |
| 15/08/2025 | Fullerton Fund Investments Pte Ltd | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | Linden Investments Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | PavCap I Feeder No. 1 LP | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | Guangzhou Nuosu Enterprise Management Partnership (Limited Partnership) | 1701(L) | +5,792,020(L) | 5,792,020(L) | 15.85 | |
| 15/08/2025 | Guangzhou Nuosu Enterprise Management Partnership (Limited Partnership) | 1701(L) | +23,168,082(L) | 23,168,082(L) | 5.51 | |
| 15/08/2025 | KIP KIS SEA-CHINA Fund | 1701(L) | +26,556,444(L) | 26,556,444(L) | 6.32 | |
| 15/08/2025 | Hong Kong Invengen Pharmaceutical Technology Co., Limited | 1701(L) | +121,278,502(L) | 121,278,502(L) | 28.56 | |
| 15/08/2025 | WANG QINGHUA | 1701(L) | +30,319,624(L) | 30,319,624(L) | 82.99 | |
| 15/08/2025 | WANG QINGHUA | 1701(L) | +121,278,502(L) | 121,278,502(L) | 28.86 | |
| 15/08/2025 | Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership) | 1701(L) | +6,554,929(L) | 6,554,929(L) | 17.94 | |
| 15/08/2025 | Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership) | 1701(L) | +26,219,717(L) | 26,219,717(L) | 6.24 | |
| 15/08/2025 | Hong Kong Invengen Pharmaceutical Technology Co., Limited | 1701(L) | +30,319,624(L) | 30,319,624(L) | 82.99 | |
| 15/08/2025 | 景得(廣州)股權投資合夥企業(有限合夥) | 1701(L) | +26,556,444(L) | 26,556,444(L) | 6.32 | |
| 15/08/2025 | 韓投夥伴（上海）創業投資管理有限責任公司 | 1701(L) | +41,731,556(L) | 41,731,556(L) | 9.93 | |
| 15/08/2025 | China International Capital Corporation Limited | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | |
| 15/08/2025 | CICC Capital Management Co., Ltd. (中金资本运营有限公司) | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | |
| 15/08/2025 | Henan Zhongjin Huirong Private Equity Fund Management Co., Ltd. | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | |
| 15/08/2025 | CICC Biomedical Fund L.P. | 1701(L) | 2,353,008(L) | 2,353,008(L) | 6.44 | |
| 15/08/2025 | Pavilion Capital GP Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | Pavilion Capital Holdings Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | Palace Investments Pte. Ltd. | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | PavCap Fund I | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | Temasek Holdings (Private) Limited | 1701(L) | 25,344,931(L) | 25,344,931(L) | 6.03 | |
| 15/08/2025 | KOREA INVESTMENT PARTNERS Co., Ltd. | 1701(L) | +41,731,556(L) | 41,731,556(L) | 9.93 | |
| 1 | ||||||
| 備註： | (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。 |
| (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 26/09/2025 17:59 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
